Amiselimod (MT-1303) acts as a modulator for the sphingosine 1-phosphate receptor (S1P receptor). It converts to its active metabolite, (S)-amiselimod phosphate, through the action of sphingosine kinases (SPHKs), specifically targeting the S1P1 receptor. This results in improvement of autoimmune disease symptoms without inducing bradycardia.
Marketplace OffersShowing from 1 suppliers
Supplier
TargetMolSC
Pack Size
Estimated Lead Time
10-14 weeks
Purity
-
$ 1,820.00
1
You cannot determine which compound library is the best fit for your project? Do you need a custom solution? AnyMol is always ready to help you.